[1]
K. Chaitanya Kasina, S. Birudaraju, and S. Rao Tirukkovalluri, “Impurity Free and Scalable Process of Sorafenib Tosyalte: Hepatocellular Carcinoma”, ajc, vol. 34, no. 3, pp. 711–714, Feb. 2022.